| |
|
|
|
|
|
|
|||
|
AC Aisenberg, BM Wilkes and NL Harris
The cell lineage of suspensions prepared from 85 non-Hodgkin's lymphomas
was investigated with a panel of 10 monoclonal antibodies and conventional
surface marker techniques. Surface immunoglobulin, assessed with specific
heteroantisera, proved to be the most useful characteristic and defined the
clonal character and B-cell lineage of 63 specimens: almost all nodular
lymphocytic (21 of 22) and diffuse lymphocytic (11 of 13) lymphomas, most
diffuse histiocytic (29 of 33) and diffuse mixed (2 of 2) lymphomas, and a
few nodular mixed (2 of 12) and nodular histiocytic (0 of 3) lymphomas.
Monoclonal antibodies provided useful ancillary surface marker criteria.
Thus, positivity with OKT1 (which detects both thymic and peripheral T
cells) in the absence of reactivity with monoclonal antisera, which detect
only peripheral T cells (OKT3, OKT4, OKT8, and OKT11), was seen only in
diffuse lymphocytic lymphoma of B lineage. Ia-like antigen could be
demonstrated in all B-cell lymphocytic lymphomas and most B-cell diffuse
histiocytic lymphomas. Approximately one-half of diffuse histiocytic
lymphomas also reacted with OKT9, which detects the transferrin receptor,
while few lymph nodes involved by other conditions displayed this
reactivity. Most diffuse histiocytic lymphomas and many non-Hodgkin's
lymphomas of other subtypes reacted with OKT10, an antiserum that detects
an antigen on replicating lymphoid cells. The lineage of approximately
one-fourth of the lymphoma suspensions was not resolved conclusively: In
most of these, T lymphocytes predominated with a normal proportion of
inducer-helper (OKT4) and cytotoxic-suppressor (OKT8) cells. The inability
to establish the clonal character of T-cell proliferation in cell
suspensions remains an obstacle to completely defining the lineage of
non-Hodgkin's lymphomas.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1983 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||